.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts
Harvard Business School
Accenture
Teva
Boehringer Ingelheim
Fish and Richardson
Mallinckrodt
Cantor Fitzgerald
Cerilliant

Generated: July 27, 2017

DrugPatentWatch Database Preview

PROMETHAZINE W/ CODEINE Drug Profile

« Back to Dashboard

What is the patent landscape for Promethazine W/ Codeine, and when can generic versions of Promethazine W/ Codeine launch?

Promethazine W/ Codeine is a drug marketed by Cenci and is included in one NDA.

The generic ingredient in PROMETHAZINE W/ CODEINE is codeine phosphate; promethazine hydrochloride. There are nineteen drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the codeine phosphate; promethazine hydrochloride profile page.

Summary for Tradename: PROMETHAZINE W/ CODEINE

Patents:0
Applicants:1
NDAs:1
Clinical Trials: see list150
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:PROMETHAZINE W/ CODEINE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cenci
PROMETHAZINE W/ CODEINE
codeine phosphate; promethazine hydrochloride
SYRUP;ORAL088814-001Nov 22, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Mallinckrodt
Fish and Richardson
Boehringer Ingelheim
Healthtrust
Chinese Patent Office
Covington
Medtronic
Harvard Business School
McKinsey
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot